Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HST-1011 |
Trade Name | |
Synonyms | HST 1011|HST1011 |
Drug Descriptions |
HST-1011 inhibits CBLB, potentially resulting in increased anti-tumor immune response (Cancer Res 2023;83(8_Suppl):Abstract nr CT251). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cemiplimab + HST-1011 | Cemiplimab HST-1011 | 0 | 1 |
HST-1011 | HST-1011 | 0 | 1 |